PMID- 35406757 OWN - NLM STAT- MEDLINE DCOM- 20220413 LR - 20230222 IS - 2073-4409 (Electronic) IS - 2073-4409 (Linking) VI - 11 IP - 7 DP - 2022 Apr 1 TI - Induction of Mitochondrial Fragmentation and Mitophagy after Neonatal Hypoxia-Ischemia. LID - 10.3390/cells11071193 [doi] LID - 1193 AB - Hypoxia-ischemia (HI) leads to immature brain injury mediated by mitochondrial stress. If damaged mitochondria cannot be repaired, mitochondrial permeabilization ensues, leading to cell death. Non-optimal turnover of mitochondria is critical as it affects short and long term structural and functional recovery and brain development. Therefore, disposal of deficient mitochondria via mitophagy and their replacement through biogenesis is needed. We utilized mt-Keima reporter mice to quantify mitochondrial morphology (fission, fusion) and mitophagy and their mechanisms in primary neurons after Oxygen Glucose Deprivation (OGD) and in brain sections after neonatal HI. Molecular mechanisms of PARK2-dependent and -independent pathways of mitophagy were investigated in vivo by PCR and Western blotting. Mitochondrial morphology and mitophagy were investigated using live cell microscopy. In primary neurons, we found a primary fission wave immediately after OGD with a significant increase in mitophagy followed by a secondary phase of fission at 24 h following recovery. Following HI, mitophagy was upregulated immediately after HI followed by a second wave at 7 days. Western blotting suggests that both PINK1/Parkin-dependent and -independent mechanisms, including NIX and FUNDC1, were upregulated immediately after HI, whereas a PINK1/Parkin mechanism predominated 7 days after HI. We hypothesize that excessive mitophagy in the early phase is a pathologic response which may contribute to secondary energy depletion, whereas secondary mitophagy may be involved in post-HI regeneration and repair. FAU - Nair, Syam AU - Nair S AUID- ORCID: 0000-0001-8470-2162 AD - Centre of Perinatal Medicine and Health, The Sahlgrenska Academy, University of Gothenburg, 41685 Gothenburg, Sweden. AD - Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden. AD - Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, 41685 Gothenburg, Sweden. FAU - Leverin, Anna-Lena AU - Leverin AL AD - Centre of Perinatal Medicine and Health, The Sahlgrenska Academy, University of Gothenburg, 41685 Gothenburg, Sweden. AD - Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden. FAU - Rocha-Ferreira, Eridan AU - Rocha-Ferreira E AUID- ORCID: 0000-0002-9342-4691 AD - Centre of Perinatal Medicine and Health, The Sahlgrenska Academy, University of Gothenburg, 41685 Gothenburg, Sweden. AD - Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden. AD - Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, 41685 Gothenburg, Sweden. FAU - Sobotka, Kristina S AU - Sobotka KS AD - Centre of Perinatal Medicine and Health, The Sahlgrenska Academy, University of Gothenburg, 41685 Gothenburg, Sweden. AD - Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden. FAU - Thornton, Claire AU - Thornton C AUID- ORCID: 0000-0001-7676-3272 AD - Department of Comparative Biomedical Sciences, Royal Veterinary College, London NW1 0TU, UK. FAU - Mallard, Carina AU - Mallard C AUID- ORCID: 0000-0001-8953-919X AD - Centre of Perinatal Medicine and Health, The Sahlgrenska Academy, University of Gothenburg, 41685 Gothenburg, Sweden. AD - Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 41390 Gothenburg, Sweden. FAU - Hagberg, Henrik AU - Hagberg H AD - Centre of Perinatal Medicine and Health, The Sahlgrenska Academy, University of Gothenburg, 41685 Gothenburg, Sweden. AD - Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, 41685 Gothenburg, Sweden. LA - eng GR - MR/T014725/1/MRC_/Medical Research Council/United Kingdom GR - WT094823/WT_/Wellcome Trust/United Kingdom GR - DH_/Department of Health/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220401 PL - Switzerland TA - Cells JT - Cells JID - 101600052 RN - 0 (FUNDC1 protein, mouse) RN - 0 (Membrane Proteins) RN - 0 (Mitochondrial Proteins) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 2.7.- (Protein Kinases) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Animals MH - Glucose MH - Hypoxia MH - Ischemia MH - Membrane Proteins/metabolism MH - Mice MH - Mitochondrial Proteins/metabolism MH - *Mitophagy/physiology MH - Protein Kinases/metabolism MH - *Ubiquitin-Protein Ligases/metabolism PMC - PMC8997592 OTO - NOTNLM OT - metabolism OT - mitochondria OT - mitochondrial fission OT - mitophagy OT - neonatal brain injury OT - neonatal hypoxia-ischemia OT - reactive oxygen species COIS- The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. EDAT- 2022/04/13 06:00 MHDA- 2022/04/14 06:00 PMCR- 2022/04/01 CRDT- 2022/04/12 01:05 PHST- 2021/12/20 00:00 [received] PHST- 2022/03/25 00:00 [revised] PHST- 2022/03/30 00:00 [accepted] PHST- 2022/04/12 01:05 [entrez] PHST- 2022/04/13 06:00 [pubmed] PHST- 2022/04/14 06:00 [medline] PHST- 2022/04/01 00:00 [pmc-release] AID - cells11071193 [pii] AID - cells-11-01193 [pii] AID - 10.3390/cells11071193 [doi] PST - epublish SO - Cells. 2022 Apr 1;11(7):1193. doi: 10.3390/cells11071193.